Safety and preliminary activity of PT2385, a first-in-class HIF2-alpha inhibitor, planned interim analysis of an open label, single-arm phase II study in patients with recurrent glioblastoma Meeting Abstract
| Authors: | Strowd, R.; Ellingson, B.; Wen, P.; Ahluwalia, M.; Piotrowski, A.; Desai, A.; Clarke, J.; Lieberman, F.; Desideri, S.; Nabors, L. B.; Grossman, S. |
| Abstract Title: | Safety and preliminary activity of PT2385, a first-in-class HIF2-alpha inhibitor, planned interim analysis of an open label, single-arm phase II study in patients with recurrent glioblastoma |
| Meeting Title: | 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology |
| Journal Title: | Neuro-Oncology |
| Volume: | 20 |
| Issue: | Suppl. 6 |
| Meeting Dates: | 2018 Nov 15-18 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 1522-8517 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-11-01 |
| Start Page: | vi14 |
| Language: | English |
| ACCESSION: | WOS:000460646300051 |
| PROVIDER: | wos |
| PMCID: | PMC6216117 |
| DOI: | 10.1093/neuonc/noy148 |
| Notes: | Meeting Abstract: ACTR-15 -- Source: Wos |
